Collegium Pharmaceutical, Inc. (COLL) Financials
COLL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.1 billion | 947.9 million |
2023-09-30 | 1.2 billion | 998.7 million |
2023-06-30 | 1.2 billion | 1.0 billion |
2023-03-31 | 1.2 billion | 1.0 billion |
COLL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 73.2 million | 7.0 million |
2023-09-30 | 74.0 million | 7.0 million |
2023-06-30 | 99.7 million | 7.1 million |
2023-03-31 | 27.5 million | 6.0 million |
COLL Net Income
No data available :(
COLL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 310.5 million | - | 7.1 million |
2023-09-30 | 304.6 million | - | 7.3 million |
2023-06-30 | 325.5 million | 571.4 million | 7.6 million |
2023-03-31 | 269.5 million | 615.0 million | 7.9 million |
COLL Shares Outstanding
COLL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 164000 | - | 32.9 million | - |
2023-09-30 | 65000 | - | 35.3 million | - |
2023-06-30 | 56000 | - | 38.2 million | - |
2023-03-31 | 176000 | - | 52.8 million | - |
COLL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 149.7 million | 55.1 million |
2023-09-30 | 136.7 million | 56.4 million |
2023-06-30 | 135.5 million | 61.7 million |
2023-03-31 | 144.8 million | 67.4 million |
COLL
Price: $37.51
52 week price:
Earnings Per Share: 1.29 USD
P/E Ratio: 141.71
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 465500
Ebitda: -13.3 millionMarket Capitalization: 1.2 billion